To the Editor: We recently reviewed the first studies of the real‐world effectiveness of coronavirus disease 2019 (COVID‐19) vaccines.1 We found evidence of protection against serious illness and death but noted the difficulties in performing such studies in Australia. This was because of the (then) low national case numbers and lack of ready access to the necessary linked health data.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.